Cardiac Catheterization Reports: Myths and Facts - Cardiology

Share to:

Myths about Test Reports


Indication: Known CAD
Pre-Cath Diagnosis: Chronic CAD
Post-Cath Diagnosis: 3VD-CAD, LM-CAD
Intervention: Yes
Complication: No
Due to the patient's condition, a surgical consultation was requested; however, the patient refused surgery after the consultation.

Stent: YES, DES
Procedure Time: (Start 20:22, Close 21:59, Duration 97 mins)
Contrast: Ominipaque: 195 ml
Vascular Access: Artery, Trans-radial (Right)
Intervention Methods: POBA, Stent
Additional Procedure: IVUS
Hemodynamics:
- Pre-procedure: BP 115/67, HR 85
- Post-procedure: BP 114/75, HR 80
Coronary Angiography:
- Dominant (Right)
- LM: Mid LM 80% stenosis
- LAD: Mid LAD 50% diffuse stenosis, mid LAD myocardial bridge ostial major DB 60% stenosis
- LCX: OM 80% stenosis
- RCA: Dominant, mid to distal RCA stent, no ISR, PDA 80% stenosis
- Ramus: Nil
- Collateral: Nil
- STNTAX score: N/A
Others (Selective Angiography): Nil
Intervention Procedure:
1.
LMCA was engaged with EBU 3.5 7F guiding catheter
2.
Runthrough wire was advanced, successfully crossing the lesion to distal LAD
3.
Sion wire was advanced to OM
4.
Pre-dilatation with 3.0x15 mm NC Raiden at 16 atm
5.
Recoil >40% noted
6.
IVUS from LAD to LM showed fibroatheroma with calcification around 90 degrees, with RVD of mid LAD 3.5-4.0 mm, proximal LAD 4.0-4.5 mm, LM 4.5-5.0 mm
7.
Stenting at mid LM to mid LAD with 3.5x48 mm Synergy DES at 8-12 atm
8.
POT with 4.0x12 mm NC Emerge at 12-16 atm
9.
IVUS from LAD to LM showed underexpansion and malapposition of stent at proximal edge
10.
Post-dilatation of stent with 3.5x20 mm NC Raiden at 8-26 atm
11.
POT with 4.5x8 mm NC Emerge at 12-16 atm
12.
IVUS from LAD to LM showed well expansion but malapposition of stent at proximal edge
13.
POT with 4.5x8 mm NC Raiden at 12-20 atm
14.
IVUS from LCX to LM showed well expansion and apposition of stent, fibroatheroma at mid LCX
15.
Optimal angiographic result
Recommendation:
1.
Continue dual antiplatelet therapy
2.
Risk factor management
ICD10:
4A023N7 - Measurement of Cardiac Sampling and Pressure, Left Heart, Percutaneous Approach
0271346 - Dilation of Coronary Artery, Two Sites, Bifurcation, with Drug-eluting Intraluminal Device, Percutaneous Approach
02713T6 - Dilation of Coronary Artery, Two Sites, Bifurcation, with Radioactive Intraluminal Device, Percutaneous Approach
02713D6 - Dilation of Coronary Artery, Two Sites, Bifurcation, with Intraluminal Device, Percutaneous Approach
Implant Name: Synergy Drug-Eluting Coronary Stent System (Model limited to specification range)
Manufacturer: Boston Scientific Corporation, Taiwan Branch
Model: H7493926248350 48x3.50 mm
Manufacturing Lot Number: 29975927
Expiration Date: 2024-08-10.

Please review this report and provide feedback in a straightforward manner.
Thank you.

Zhang, 40~49 year old female. Ask Date: 2024/02/28

Dr. Li Han reply Cardiology


Hello, this report includes the diagnosis, treatment decision-making process, doctor-patient discussion options, and records of the intervention process.
It is recommended that you discuss this with your attending physician for a more appropriate approach.
Changhua Hospital, Ministry of Health and Welfare, cares about you.

Reply Date: 2024/02/28

More Info


Understanding cardiac catheterization reports can be challenging, especially when it comes to interpreting the medical jargon and the implications of the findings. Here’s a breakdown of the key components of your report, along with some context to help clarify what they mean.


Indications and Diagnoses
- Indication: Known coronary artery disease (CAD) indicates that the patient has a history of heart disease, which is a significant risk factor for further cardiovascular events.

- Pre-Cath Diagnosis: Chronic CAD suggests that the patient has long-standing issues with their coronary arteries, which may include blockages or narrowing.

- Post-Cath Diagnosis: The report indicates "3VD-CAD" (three-vessel disease) and "LM-CAD" (left main coronary artery disease), which are serious conditions that often require intervention due to the high risk of heart attacks.


Intervention Details
- Intervention: The report states that an intervention was performed, specifically the placement of a drug-eluting stent (DES) in the coronary arteries. This is a common procedure to open blocked arteries and improve blood flow.

- Complications: Notably, there were no complications reported during the procedure, which is a positive outcome.


Procedure Specifics
- Stent Placement: The stent was placed in the left main coronary artery (LMCA) and mid-left anterior descending artery (LAD). The use of a drug-eluting stent helps to prevent the artery from becoming blocked again.

- Contrast Used: Ominipaque was used as a contrast agent during the procedure, which helps visualize the coronary arteries on imaging studies.


Hemodynamics
- Blood Pressure and Heart Rate: The report provides pre- and post-procedure vital signs, showing stable blood pressure and heart rate, which is a good sign of the patient's stability during and after the procedure.


Angiography Findings
- Stenosis: The report details various degrees of stenosis (narrowing) in different coronary arteries, with significant blockages noted in the left main artery and other branches. This information is crucial for understanding the severity of the CAD.

- IVUS (Intravascular Ultrasound): This technique was used to assess the condition of the arteries more closely, revealing the presence of fibroatheroma (a type of plaque) and confirming the need for stenting.


Recommendations
- Dual Antiplatelet Therapy: The recommendation to continue dual antiplatelet therapy is standard after stent placement to reduce the risk of clot formation on the stent.

- Risk Factor Management: This includes lifestyle changes and possibly medications to manage cholesterol, blood pressure, and other risk factors for heart disease.


Conclusion
In summary, your report indicates that you have significant coronary artery disease, which was addressed through a successful catheterization procedure involving stenting. The absence of complications is reassuring, and the recommendations for ongoing medication and risk factor management are critical for your long-term health. It is essential to follow up with your healthcare provider to monitor your condition and make any necessary adjustments to your treatment plan.

If you have any further questions or concerns about your report or your health, it is advisable to discuss them directly with your cardiologist, who can provide personalized guidance based on your medical history and current condition.

Similar Q&A

Understanding the Accuracy of Cardiac Catheterization: Insights and Considerations

What is the accuracy of cardiac catheterization? Is this examination reliant on the physician or the equipment for judgment? Is there a possibility of misinterpreting a blockage as non-blockage, or is there a discrepancy in assessing the severity of the blockage? I have seen onli...


Dr. Cai Guiqin reply Cardiology
It is recommended to consult with a cardiology outpatient clinic. Thank you, and wishing you good health.

[Read More] Understanding the Accuracy of Cardiac Catheterization: Insights and Considerations


Understanding Cardiac Catheterization: Purpose, Risks, and What to Expect

Hello Dr. Lee: I went for a check-up for heart disease, and in addition to an electrocardiogram and cardiac imaging, the doctor is now requesting that I be hospitalized for a cardiac catheterization. What is cardiac catheterization? Why is this test necessary, and why do I need t...


Dr. Li Huixiong reply Internal Medicine
In simple terms, cardiac catheterization or cardiac catheter therapy refers to the procedure of inserting a thin tube through the skin and into the blood vessels to reach the heart for further examination, evaluation, or treatment. From your description, it is understood that you...

[Read More] Understanding Cardiac Catheterization: Purpose, Risks, and What to Expect


Understanding Risks and Complications of Cardiac Catheterization

My brother needs to undergo a cardiac catheterization due to a myocardial infarction. However, I have heard about the risk of stroke following the procedure. What are the reasons for this? How high is the risk? If there are any complications, how would the physician handle them i...


Dr. Huang Guosheng reply Cardiology
Cardiac catheterization involves advancing a catheter through the radial or femoral artery to the coronary arteries of the heart. However, during this process, there is a risk of dislodging a blood clot from the aorta, which could lead to a stroke. The incidence of this complicat...

[Read More] Understanding Risks and Complications of Cardiac Catheterization


Understanding Cardiac Catheterization: Insights on Myocardial Ischemia Detection

Dear Doctor, In January 2018, I was diagnosed with moderate mitral valve regurgitation. In September 2019, I experienced chest tightness and difficulty breathing, leading to a myocardial perfusion scan, which revealed moderate ischemia in the anterior wall. I was then referred t...


Dr. He Dongjin reply Cardiology
Hello, cardiac catheterization can detect myocardial ischemia. This procedure provides information about cardiovascular status, including the presence of any stenosis. A normal result indicates that there are no issues, so there is no need to worry. Changhua Hospital cares about ...

[Read More] Understanding Cardiac Catheterization: Insights on Myocardial Ischemia Detection


Related FAQ

Cardiac Catheterization

(Cardiology)

Post-Cardiac Catheterization

(Cardiology)

Ct Scan Report

(Cardiology)

Health Check-Up Report

(Cardiology)

Coronary Artery Obstruction

(Cardiology)

Coronary Stent

(Cardiology)

Heart Valve

(Cardiology)

Afib

(Cardiology)

Pacs

(Cardiology)

Vein

(Cardiology)